Dimbeon success in Huntingtons trial
Posted: Mon Feb 08, 2010 1:58 pm
This antihistamin drug is also evaluated in Alzheimers (Phase-III) due to its potential neuroprotective effects:
http://www.physorg.com/news184860820.html
--Frank
http://www.physorg.com/news184860820.html
--Frank